Human chorionic gonadotropin treatment of anti-Hu-associated paraneoplastic neurologicalsyndromes

Autor: Herbert Hooijkaas, F van Broekhoven, Jacoline E C Bromberg, M. T. de Graaf, N A Khan, Maarten A. Frens, M. J. van den Bent, R Benner, J. W. de Beukelaar, P. A. E. Sillevis Smitt, J.N. van der Geest, Jan-Willem Gratama
Přispěvatelé: Neurosciences, Neurology, Immunology, Medical Oncology, Radiology & Nuclear Medicine
Rok vydání: 2010
Předmět:
Zdroj: Journal of Neurology Neurosurgery and Psychiatry, 81(12), 1341-1344. BMJ Publishing Group
ISSN: 0022-3050
DOI: 10.1136/jnnp.2009.177865
Popis: Objective Paraneoplastic neurological syndromes associated with anti-Hu antibodies (Hu-PNS) are mediated by a T-cell immune response that is directed against the Hu antigens. In pregnancy, many Th1-mediated autoimmune diseases such as rheumatoid arthritis and multiple sclerosis regress. We hypothesised that this decreased disease activity during pregnancy may be related to high human chorionic gonadotropin (hCG) levels. Methods 15 Hu-PNS patients were treated in a prospective, uncontrolled and unblinded trial with 10 000 IU daily of hCG administered by intramuscular injection during 12 weeks. Primary outcome measures were functional improvement defined as a decrease of one or more points on the modified Rankin Scale (mRS) or stabilisation in patients with mRS score = 1 point. Five patients improved on the Barthel Index (33%). Conclusion Comparison with previous studies suggests that hCG may have immunomodulatory activity and may modify the course of Hu-PNS, although well-established confounding factors may have contributed in this uncontrolled trial.
Databáze: OpenAIRE